Orestis_KO

Orestis_KO

Perhaps one of the most (in my opinion THE most) undervalued uranium stock in the market. Having shown some great reaction near the $1/20-$1.25 zone, in these levels the stock is a buy. With most analysts predicting increasing demand for Uranium and its peers trading way higher, URG is definitely a candidate for massive returns. Personally my average is near...

Orestis_KO Updated 

Stock price is stagnant (more or less) since falling rapidly from ATHs. In 2024, prices consolidates between $4.5 and $6.5. OBV is on the rise (despite being negative), which implies that buyers stepping in. The main point for initiating a long position in RSKD is the Market Cap. At around $800 million, with annual revenues of $300 million (++) and a growing...

Orestis_KO

With OBV nearing ATH, a decent earnings report and a breakout from a descending triangle, EXAE seems like the perfect candidate for an easy 30% profit. Entry at €4.45 and price target at €5.90. Based on market conditions when stock price will reach our take profit target, we will reconsider whether closing the position (or part of it) is the best choice or if...

Orestis_KO

Trading near 8-year lows (not considering COVID-19 drop) VALE seems way undervalued both from PE - PS ratio standpoint and also when comparing with its peers. The stock price has reacted three times in $9.75 - $9.80 level. The period of November-December is the starting point of price appreciation since 2021 (although each time the rise in price was not as great...

Orestis_KO

Based on RSI and price action, it seems that $25 is a good entry for a swing trade with TP at $29.50+, before next earnings report. The stock has done that move two times from December 2023. The only alarming factor is the sharp fall of OBV, but the risk-reward ratio of the play is very attractive.